Anti-TNF Biological Agents in Rheumatoid Arthritis and Other Inflammatory Diseases
スポンサーリンク
概要
- 論文の詳細を見る
- 2005-06-01
著者
-
TAKEUCHI Tsutomu
Division of Particle and Astrophysical Sciences, Nagoya University
-
Kameda Hideto
Division of Rheumatology, Department of Internal Medicine, School of Medicine, Keio University, Japa
-
Kameda Hideto
Department Of Rheumatology And Clinical Immunology Saitama Medical Center Saitama Medical University
-
Takeuchi Tsutomu
Department Of Rheumatology And Clinical Immunology Saitama Medical Center Saitama Medical University
-
Amano Koichi
Department Of Rheumatology And Clinical Immunology Saitama Medical Center Saitama Medical University
-
Kameda Hideto
Division Of Rheumatology And Clinical Immunology Department Of Internal Medicine Faculty Of Medicine
-
AMANO Kouichi
Division of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University
-
ABE Toru
Saitama Medical School
-
Kameda Hideto
Division Of Rheumatology Saitama Medical Center Saitama Medical School
-
Amano Kouichi
Division Of Rheumatology Saitama Medical Center Saitama Medical School
-
Kameda Hideto
Department Of Rheumatology/clinical Immunology Saitama Medical Center
-
Takeuchi Tsutomu
Division Of Rheumatology School Of Medicine Keio University
-
Takeuchi Tsutomu
Division Of Particle And Astrophysical Sciences School Of Science Nagoya University
-
Amano Kouichi
Division Of Rheumatology And Clinical Immunology Department Of Internal Medicine Saitama Medical Center Saitama Medical University
関連論文
- Exploring Galaxy Evolution from Infrared Number Counts and Cosmic Infrared Background
- Clinical and Radiological Features of Acute-Onset Diffuse Interstitial Lung Diseases in Patients with Rheumatoid Arthritis Receiving Treatment with Biological Agents: Importance of Pneumocystis Pneumonia in Japan Revealed by a Multicenter Study
- Severe degenerative change of multiple organs mediated by chronic active Epstein-Barr virus infection with infected T-cell expansion
- Impact of trough serum level on radiographic and clinical response to infliximab plus methotrexate in patients with rheumatoid arthritis : results from the RISING study
- Aberrant expression of BAFF in T cells of systemic lupus erythematosus, which is recapitulated by a human T cell line, Loucy
- Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan : one-year outcome of joint destruction (RECONFIRM-2J)
- Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan : one-year clinical outcomes (RECONFIRM-2)
- Retrospective clinical study on the notable efficacy and related factors of infliximab therapy in a rheumatoid arthritis management group in Japan (RECONFIRM)
- Differences between the Health Assessment Questionnaire Disability Index (HAQ-DI) and the modified HAQ (mHAQ) score before and after infliximab treatment in patients with rheumatoid arthritis
- Improvement of the HAQ score by infliximab treatment in patients with RA : its association with disease activity and joint destruction
- Development and validation of handy rheumatoid activity score with 38 joints (HRAS38) in rheumatoid arthritis patients receiving infliximab
- Impact of TNF inhibitors on rheumatoid arthritis
- Efficacy and safety of bucillamine, a D-penicillamine analogue, in patients with active rheumatoid arthritis
- Anti-TNF Biological Agents in Rheumatoid Arthritis and Other Inflammatory Diseases
- Factors predicting the response to low-dose methotrexate therapy in patients with rheumatoid arthritis : a better response in male patients
- Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis
- Guidelines for the proper use of etanercept in Japan
- Notable Difference between the Development of Vertebral Fracture and Osteonecrosis of the Femoral Head in Patients Treated with High-dose Glucocorticoids for Systemic Rheumatic Diseases
- The Relative Neighborhood Graph for Estimating Two-Dimensional Voids in the Cold Dark Matter Universe
- Deep 15μm AKARI Observations in the CDFS : Estimating Dust Luminosities for a MIR-Selected Sample and for Lyman Break Galaxies and the Evolution of L_/L_ with the Redshift
- Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy : a randomized trial
- The Radio-to-Submillimeter Flux Density Ratio of Galaxies as a Measure of Redshift
- A Graph-Theoretical Approach for Quantifying Two-Dimensional Galaxy Distributions and Comparison with Cold Dark Matter Universe
- Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients
- Efficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan : results from a retrospective study (REACTION study)
- Postmarketing surveillance of safety and effectiveness of etanercept in Japanese patients with rheumatoid arthritis
- Revolutionary Change in Rheumatoid Arthritis Management with Biological Therapy
- Safety and effectiveness responses to etanercept for rheumatoid arthritis in Japan: a sub-analysis of a post-marketing surveillance study focusing on the duration of rheumatoid arthritis
- Safety and effectiveness of switching from infliximab to etanercept in patients with rheumatoid arthritis: results from a large Japanese postmarketing surveillance study
- Lansoprazole for secondary prevention of gastric or duodenal ulcers associated with long-term non-steroidal anti-inflammatory drug (NSAID) therapy : results of a prospective, multicenter, double-blind, randomized, double-dummy, active-controlled trial
- AKARI/IRC Broadband Mid-Infrared Data as an Indicator of the Star-Formation Rate
- Structural damages disturb functional improvement in patients with rheumatoid arthritis treated with etanercept
- Effectiveness and safety of adalimumab in Japanese patients with rheumatoid arthritis : retrospective analyses of data collected during the first year of adalimumab treatment in routine clinical practice (HARMONY study)
- A Case of Multiple Giant Coronary Aneurysms and Abdominal Aortic Aneurysm Coexisting with IgG4-related Disease
- Successful Treatment of Class IV+V Lupus Nephritis with Combination Therapy of High-dose Corticosteroids, Tacrolimus and Intravenous Cyclophosphamide
- Pneumocystis jirovecii pneumonia associated with etanercept treatment in patients with rheumatoid arthritis : a retrospective review of 15 cases and analysis of risk factors
- Discontinuation of adalimumab treatment in rheumatoid arthritis patients after achieving low disease activity
- Far-ultraviolet and far-infrared bivariate luminosity function of galaxies : Complex relation between stellar and dust emission
- A retrospective study of serum KL-6 levels during treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients : a report from the Ad Hoc Committee for Safety of Biological DMARDs of the Japan College of Rheumatology
- Phase II dose-response study of abatacept in Japanese patients with active rheumatoid arthritis with an inadequate response to methotrexate
- Tolerability and effecacy of abatacept in Japanese patients with rheumatoid arthritis : a phase I study